BACK TO TOP
KSE100
185,543.01
0.00
(0.00%)
KSE100PR
58,284.44
0.00
(0.00%)
ALLSHR
110,883.94
0.00
(0.00%)
KSE30
56,997.99
0.00
(0.00%)
KMI30
261,472.17
0.00
(0.00%)
BKTI
54,074.14
0.00
(0.00%)
OGTI
36,259.38
0.00
(0.00%)
KMIALLSHR
71,138.28
0.00
(0.00%)
PSXDIV20
82,818.87
0.00
(0.00%)
UPP9
64,982.58
0.00
(0.00%)
NITPGI
48,453.08
0.00
(0.00%)
NBPPGI
52,548.84
0.00
(0.00%)
MZNPI
32,149.97
0.00
(0.00%)
JSMFI
49,263.88
0.00
(0.00%)
ACI
26,078.47
0.00
(0.00%)
JSGBKTI
79,079.11
0.00
(0.00%)
HBLTTI
17,898.93
08-01-2026
0.10
(0.00%)
MII30
23,840.64
0.00
(0.00%)
Abbott Laboratories (Pakistan) Limited
PHARMACEUTICALS
Rs.1,257.76
48.27
(3.99%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Thu, Jan 8, 2026 3:46 PM
REG
DFC
CSF
ODL
Open
1,209.49
High
1,274.00
Low
1,121.00
Volume
58,224
CIRCUIT BREAKER
1,131.98 — 1,383.54
DAY RANGE
1,121.00 — 1,274.00
52-WEEK RANGE ^
790.00 — 1,310.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
1,257.76
VAR
11.50
HAIRCUT
22.50
P/E Ratio (TTM) **
18.52
1-Year Change * ^
4.81%
YTD Change * ^
19.77%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

KEY PEOPLE
Syed Anis AhmedCEO
Ehsan A. MalikChairperson
Muhammad Usama JamilCompany Secretary
ADDRESS

Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan

WEBSITE

www.pk.abbott

REGISTRAR

FAMCO Share Registration Services (Pvt) Limited, 8-F, Next to Hotel Faran, Nursery Block 6, P.E.C.H.S, Shahrah-e-Faisal,Karachi

AUDITOR

EY Ford Rhodes, Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
123,135,083.84
Shares
97,900,302
Free Float
21,144,961
Free Float
21.60%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2025Transmission of Quarterly Reports for the Period Ended September 30, 2025 View   PDF
Oct 29, 2025Financial Results for the Quarter Ended September 30, 2025 View   PDF
Aug 29, 2025Transmission of Quarterly Account for the Period Ended June 30, 2025 View   PDF
Aug 28, 2025Financial Results for the Quarter Ended June 30, 2025 View   PDF
Apr 30, 2025Transmission of Quarterly Report for the Period Ended March 31, 2025 View   PDF
DateTitleDocument
Oct 22, 2025Board Meeting View   PDF
Aug 20, 2025Board Meeting View   PDF
Apr 23, 2025Certified copy of Resolutions passed at the 76th Annual General Meeting View   PDF
Apr 21, 2025Board Meeting View   PDF
Mar 25, 2025Notice of Annual General Meeting View   PDF
DateTitleDocument
Dec 30, 2025ABOT | Abbott Laboratories (Pakistan) Limited Revised Presentation of Corporate Briefing Session 2025
REVISED
PDF
Dec 30, 2025ABOT | Abbott Laboratories (Pakistan) Limited Corporate Briefing Session (CBS)
REVOKED
PDF
Dec 29, 2025Presentation of Corporate Briefing Session 2025 View   PDF
Dec 26, 2025Corporate Briefing Session 2025 View   PDF
Nov 25, 2025Appointment of Director View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2024202320222021
Sales68,177,19755,475,27049,257,72242,569,856
Profit after Taxation5,234,233261,7773,004,1865,967,057
EPS53.462.6730.6960.95
Q3 2025Q2 2025Q1 2025Q3 2024
Sales19,819,13419,061,33817,346,45117,364,546
Profit after Taxation1,822,5461,943,4991,599,6731,809,143
EPS18.6219.8516.3418.48
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2024202320222021
Gross Profit Margin (%)28.9521.3629.4937.76
Net Profit Margin (%)7.680.476.1014.02
EPS Growth (%)1,902.25(91.30)(49.65)31.56
PEG0.01(1.89)(0.30)0.37

Payouts

Financial Reports